Mitochondrial Artificial K + Channel Construction Using MPTPP@5F8 Nanoparticles for Overcoming Cancer Drug Resistance via Disrupting Cellular Ion Homeostasis
Advanced Healthcare Materials · 2024-01 · 13 (2)
DOI: 10.1002/adhm.202302012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.10.2023. Verfasst von Panqin Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sci…. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Shenzhen Science and Innovation Committee.
Abstract (Originalsprache)
Mitochondrial potassium ion channels have become a promising target for cancer therapy. However, in malignant tumors, their low expression or inhibitory regulation typically leads to undesired cancer therapy, or even induces drug resistance. Herein, this work develops an in situ mitochondria‐targeted artificial K + channel construction strategy, with the purpose to trigger cancer cell apoptosis by impairing mitochondrial ion homeostasis. Considering the fact that cancer cells have a lower membrane potential than that of normal cells, this strategy can selectively deliver artificial K + channel molecule 5F8 to the mitochondria of cancer cells, by using a mitochondria‐targeting triphenylphosphine (TPP) modified block polymer (MPTPP) as a carrier. More importantly, 5F8 can further specifically form a K + ‐selective ion channel through the directional assembly of crown ethers on the mitochondrial membrane, thereby inducing mitochondrial K + influx and disrupting ions homeostasis. Thanks to this design, mitochondrial dysfunction, including decreased mitochondrial membrane potential, reduced adenosine triphosphate (ATP) synthesis, downregulated antiapoptotic BCL‐2 and MCL‐1 protein levels, and increased reactive oxygen species (ROS) levels, can further effectively induce the programmed apoptosis of multidrug‐resistant cancer cells, no matter in case of pump or nonpump dependent drug resistance. In short, this mitochondria‐targeted artificial K + ‐selective ion channel construction strategy may be beneficial for potential drug resistance cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.
- Institute of Materials Research and Engineering, A*STAR (Agency for Science, Technology and Research), 2 Fusionopolis Way, Innovis, #08-03, Singapore, 138634, Singapore.
- Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), A*STAR (Agency for Science, Technology and Research), 1 Pesek Road, Jurong Island, Singapore, 627833, Singapore.
- Shenzhen Research Institute of Xiamen University, Shenzhen, Guangdong, 518057, China.
ORCID-Profile: Zibiao Li
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Shenzhen Science and Innovation Committee
- National Key Research and Development Program of China
Zitieren
APA
Ma, P., Luo, Z., Li, Z., Lin, Y., Li, Z., Wu, Z., Ren, C., & Wu, Y. L. (2024). Mitochondrial Artificial K + Channel Construction Using MPTPP@5F8 Nanoparticles for Overcoming Cancer Drug Resistance via Disrupting Cellular Ion Homeostasis. Advanced Healthcare Materials, 13(2). https://doi.org/10.1002/adhm.202302012
Vancouver
Ma P, Luo Z, Li Z, Lin Y, Li Z, Wu Z, et al. Mitochondrial Artificial K + Channel Construction Using MPTPP@5F8 Nanoparticles for Overcoming Cancer Drug Resistance via Disrupting Cellular Ion Homeostasis. Advanced Healthcare Materials. 2024;13(2). doi:10.1002/adhm.202302012
BibTeX
@article{Ma2024,
author = {Ma, Panqin and Luo, Zheng and Li, Zhiguo and Lin, Yuchao and Li, Zibiao and Wu, Zhen and Ren, Changliang and Wu, Yun-Long},
title = {Mitochondrial Artificial K + Channel Construction Using MPTPP@5F8 Nanoparticles for Overcoming Cancer Drug Resistance via Disrupting Cellular Ion Homeostasis},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {2},
doi = {10.1002/adhm.202302012}
}
EUVIMED